167 28 Dixit MP, Cabansag MR, Piscitelli J, Greifer I, Silverstein DM Serum beta2 microglobulin and immunoglobulin levels in young hemodialysis patients Pediatr Nephrol 1999;13(2) 139–42 29 Chadha V,[.]
11 Preservation of Residual Renal Function in Children Reaching End-Stage Renal Disease 28 Dixit MP, Cabansag MR, Piscitelli J, Greifer I, Silverstein DM. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients Pediatr Nephrol 1999;13(2):139–42 29 Chadha V, Blowey DL, Warady BA. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int 2001;21(Suppl 3):S179–84 30 Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition Perit Dial Int 2000;20(4):439–44 31 Poulsen CG, Kjaergaard KD, Peters CD, Jespersen B, Jensen JD. Quality of life development during initial hemodialysis therapy and association with loss of residual renal function Hemodial Int 2017;21(3):409–21 32 Park HC, Lee H, Lee JP, Kim DK, Oh KH, Joo KW, et al Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients J Korean Med Sci 2012;27(1):64–71 33 Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study Am J Kidney Dis 2010;56(2):348–58 34 Erkan E, Moritz M, Kaskel F. Impact of residual renal function in children on hemodialysis Pediatr Nephrol 2001;16(11):858–61 35 Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, et al Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Ann Intern Med 2003;139(4):244–52 36 Tkaczyk M, Nowicki M, Balasz-Chmielewska I, Boguszewska-Baczkowska H, Drozdz D, Kollataj B, et al Hypertension in dialysed children: the prevalence and therapeutic approach in Poland – a nationwide survey Nephrol Dial Transplant 2006;21(3):736–42 37 Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients Kidney Int 2002;62(3):1046–53 38 Hidaka H, Nakao T. Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis Nephrology (Carlton) 2003;8(4):184–91 39 Roszkowska-Blaim M, Skrzypczyk P. Risk factors for decline of residual renal function in children treated with peritoneal dialysis Perit Dial Int 2016;36(6):669–75 40 Uchiyama K, Yanai A, Maeda K, Ono K, Honda K, Tsujimoto R, et al Baseline and time-averaged values predicting residual renal function decline rate 167 in Japanese peritoneal dialysis patients Ther Apher Dial 2017;21(6):599–605 41 Mitsnefes M, Ho P-L, McEnery P. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) J Am Soc Nephrol 2003;14(10):2618–22 42 Litwin M. Risk factors for renal failure in children with non-glomerular nephropathies Pediatr Nephrol 2004;19(2):178–86 43 Tian JP, Wang H, Tian XK, Du FH, Wang T. The impact of visit-to-visit systolic blood pressure variability on residual renal function and left ventricular hypertrophy in peritoneal dialysis patients Turk J Med Sci 2018;48(2):279–85 44 Neild GH. What we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease Pediatr Nephrol 2009;24(10):1921–8 45 Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, et al Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis Kidney Int 2015;88(3):605–13 46 Wingen AM, Fabian-Bach C, Schaefer F, Mehls O. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood Lancet 1997;349(9059):1117–23 47 Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, et al Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study Clin J Am Soc Nephrol 2009;4(4):812–9 48 Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al Strict blood-pressure control and progression of renal failure in children N Engl J Med 2009;361(17):1639–50 49 Wuehl E, Mehls O, Schaefer F, ESCAPE Trial Group Long-term dissociation of antiproteinuric and antihypertensive efficacy of ACE inhibition in children with chronic renal failure.COD.OC 16 [Abstract] Pediatr Nephrol 2006;21:1505 50 Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous p eritoneal dialysis and factors affecting it Perit Dial Int 2000;20(4):429–38 51 Roszkowska-Blaim M, Skrzypczyk P, Jander A, Tkaczyk M, Balasz-Chmielewska I, Zurowska A, et al The effect of peritoneal dialysis method on residual renal function in children Adv Perit Dial 2012;28:112–9 52 Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, et al Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients Perit Dial Int 1999;19(2):138–42 53 de Fijter CW, ter Wee PM, Donker AJ. The influence of automated peritoneal dialysis on the decrease in 168 residual renal function Nephrol Dial Transplant 2000;15(7):1094–6 54 Liao CT, Shiao CC, Huang JW, Hung KY, Chuang HF, Chen YM, et al Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients Perit Dial Int 2008;28(Suppl 3):S191–5 55 Szeto CC, Kwan BC, Chow KM, Chung S, Yu V, Cheng PM, et al Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis Perit Dial Int 2015;35(2):180–8 56 Feber J, Schrer K, Schaefer F, Mkov M, Janda J. Residual renal function in children on haemodialysis and peritoneal dialysis therapy Pediatr Nephrol 1994;8(5):579–83 57 Van Biesen W, Dequidt C, Vanholder R, Lameire N. The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters Adv Perit Dial 2002;18:44–8 58 Furth SL, Cole SR, Fadrowski JJ, Gerson A, Pierce CB, Chandra M, et al The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease Pediatr Nephrol 2007;22(2):265–71 59 Gouva C, Nikolopoulos P, Ioannidis JPA, Siamopoulos K. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial Kidney Int 2004;66(2):753–60 60 Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients Kidney Int 2002;62(2):639–47 61 Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, et al Management of anemia in children receiving chronic peritoneal dialysis J Am Soc Nephrol 2013;24(4):665–76 62 Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment Am J Kidney Dis 2005;45(6):978–93 63 Harambat J, Kunzmann K, Azukaitis K, Bayazit AK, Canpolat N, Doyon A, et al Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease Kidney Int 2017;92(6):1507–14 64 de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status J Am Soc Nephrol 2009;20(9):2075–84 65 Chalmers L, Kaskel FJ, Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease Adv Chronic Kidney Dis 2006;13(4):352–64 66 Soares CM, Diniz JS, Lima EM, Oliveira GR, Canhestro MR, Colosimo EA, et al Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme Nephrol Dial Transplant 2009;24(3):848–55 I.-S Ha and F Schaefer 67 Han KH, Lee SH, Lee HK, Choi HJ, Lee BH, Cho HY, et al Risk factors for the progression of pediatric chronic kidney disease-a single center study J Korean Soc Pediatr Nephrol 2007;11(2):239–46 68 Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, et al The bone and mineral disorder of children undergoing chronic peritoneal dialysis Kidney Int 2010;78(12):1295–304 69 Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al Predictors of loss of residual renal function among new dialysis patients J Am Soc Nephrol 2000;11(3):556–64 70 Noordzij M, Voormolen NM, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients Nephrol Dial Transplant 2009;24(5):1580–7 71 Park JT, Kim DK, Chang TI, Kim HW, Chang JH, Park SY, et al Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients Nephrol Dial Transplant 2009;24(11):3520–5 72 Hsieh YP, Yang Y, Chang CC, Kor CT, Wen YK, Chiu PF, et al U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal dialysis patients Nephrology (Carlton) 2017;22(6):427–35 73 Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long- term peritoneal dialysis Nephrol Dial Transplant 2009;24(9):2909–14 74 Liu JH, Wang SM, Chen CC, Hsieh CL, Lin SY, Chou CY, et al Relation of ankle-brachial index to the rate of decline of residual renal function in peritoneal dialysis patients Nephrology (Carlton) 2011;16(2):187–93 75 Caliskan Y, Ozkok A, Akagun T, Alpay N, Guz G, Polat N, et al Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients Kidney Blood Press Res 2012;35(5):340–8 76 Tian SL, Tian XK, Han QF, Axelsson J, Wang T. Presence of peripheral arterial disease predicts loss of residual renal function in incident CAPD patients Perit Dial Int 2012;32(1):67–72 77 Davenport A, Sayed RH, Fan S. Is extracellular volume expansion of peritoneal dialysis patients associated with greater urine output? Blood Purif 2011;32(3):226–31 78 Tian N, Guo Q, Zhou Q, Cao P, Hong L, Chen M, et al The impact of fluid overload and variation on residual renal function in peritoneal dialysis patient PLoS One 2016;11(4):e0153115 79 Kawai Y, Tanaka S, Yoshida H, Hara M, Tsujikawa H, Tsuruya K, et al Association of B-type natriuretic peptide level with residual kidney function in incident peritoneal dialysis patients Perit Dial Int 2019;39(2):147–54 11 Preservation of Residual Renal Function in Children Reaching End-Stage Renal Disease 80 Ardissino G, Testa S, Dacc V, Vigan S, Taioli E, Claris-Appiani A, et al Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy Data from the Ital Kid Project Pediatr Nephrol 2004;19(2):172–7 81 Lane PH. Puberty and chronic kidney disease Adv Chronic Kidney Dis 2005;12(4):372–7 82 Tonshoff B, Fine RN. Recombinant human growth hormone for children with renal failure Adv Ren Replace Ther 1996;3(1):37–47 83 Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, et al Association of body mass index with decline in residual kidney function after initiation of dialysis Am J Kidney Dis 2009;53(6):1014–23 84 Papp F, Friedman AL, Bereczki C, Haszon I, Kiss E, Endreffy E, et al Renin-angiotensin gene polymorphism in children with uremia and essential hypertension Pediatr Nephrol 2003;18(2):150–4 85 Hohenfellner K, Wingen AM, Nauroth O, Whl E, Mehls O, Schaefer F. Impact of ACE I/D gene polymorphism on congenital renal malformations Pediatr Nephrol 2001;16(4):356–61 86 Oktem F, Sirin A, Bilge I, Emre S, Agachan B, Ispir T. ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome Pediatr Nephrol 2004;19(4):384–9 87 Amoroso A, Danek G, Vatta S, Crovella S, Berrino M, Guarrera S, et al Polymorphisms in angiotensin- converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients Italian Group of Renal Immunopathology Nephrol Dial Transplant 1998;13(12):3184–8 88 Hussein A, Askar E, Elsaeid M, Schaefer F. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection Nephrol Dial Transplant 2010;25(3):779–85 89 Xu J, Guo Z, Bai Y, Zhang J, Cui L, Zhang H, et al Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with the kidney survival time in chronic kidney disease patients Ren Fail 2015;37(1):108–12 90 Bodonyi-Kovacs G, Ma JZ, Chang J, Lipkowitz MS, Kopp JB, Winkler CA, et al Combined effects of GSTM1 null allele and APOL1 renal risk alleles in CKD progression in the African American Study of Kidney Disease and Hypertension trial J Am Soc Nephrol 2016;27(10):3140–52 91 Tin A, Grams ME, Estrella M, Lipkowitz M, Greene TH, Kao WH, et al Patterns of kidney function decline associated with APOL1 genotypes: results from AASK. Clin J Am Soc Nephrol 2016;11(8):1353–9 92 Rudnicki M, Perco P, Haene BD, Leierer J, Heinzel A, Muhlberger I, et al Renal microRNA- and RNA- profiles in progressive chronic kidney disease Eur J Clin Investig 2016;46(3):213–26 169 93 Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, et al Genome-wide association of CKD progression: the chronic renal insufficiency cohort study J Am Soc Nephrol 2017;28(3):923–34 94 Xu X, Eales JM, Akbarov A, Guo H, Becker L, Talavera D, et al Molecular insights into genome- wide association studies of chronic kidney disease- defining traits Nat Commun 2018;9(1):4800 95 Wuttke M, Wong CS, Wuhl E, Epting D, Luo L, Hoppmann A, et al Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium Nephrol Dial Transplant 2016;31(2):262–9 96 Lang SM, Bergner A, Topfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors Perit Dial Int 2001;21(1):52–7 97 Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis Kidney Int 2001;59(2):754–63 98 Feber J, Scharer K, Schaefer F, Mikova M, Janda J. Residual renal function in children on haemodialysis and peritoneal dialysis therapy Pediatr Nephrol 1994;8(5):579–83 99 Fischbach M, Terzic J, Menouer S, Soulami K, Dangelser C, Helmstetter A, et al Effects of automated peritoneal dialysis on residual daily urinary volume in children Adv Perit Dial 2001;17:269–73 100 Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A. Rapid decline of residual renal function in patients on automated peritoneal dialysis Perit Dial Int 1996;16(3):307–15 101 Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function Nephrol Dial Transplant 1999;14(5):1224–8 102 Michels WM, Verduijn M, Grootendorst DC, le Cessie S, Boeschoten EW, Dekker FW, et al Decline in residual renal function in automated compared with continuous ambulatory peritoneal dialysis Clin J Am Soc Nephrol 2011;6(3):537–42 103 Bernardo A, Fonseca I, Rodrigues A, Carvalho MJ, Cabrita A. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor? Adv Perit Dial 2009;25:110–4 104 Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients Perit Dial Int 2001;21(3):302–5 105 Dell’Aquila R, Berlingo G, Pellanda MV, Contestabile A. Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: are there differences in outcome? Contrib Nephrol 2009;163:292–9 170 106 Balasubramanian G, McKitty K, Fan SL. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Nephrol Dial Transplant 2011;26(5):1702–8 107 Cnossen TT, Usvyat L, Kotanko P, van der Sande FM, Kooman JP, Carter M, et al Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database Perit Dial Int 2011;31(6):679–84 108 Adachi Y, Nishio A, Ikegami T. Tidal automated peritoneal dialysis preserves residual renal function better than non tidal automated peritoneal dialysis Adv Perit Dial 2007;23:98–101 109 Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville NC, Wiggins KJ, et al Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function Nephrol Dial Transplant 2012;27(1):381–7 110 Baker RJ, Senior H, Clemenger M, Brown EA. Empirical aminoglycosides for peritonitis not affect residual renal function Am J Kidney Dis 2003;41(3):670–5 111 Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients Am J Kidney Dis 1999;34(1):14–20 112 Wuhl E, Mehls O, Schaefer F, ESCAPE Trial Group Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure Kidney Int 2004;66(2):768–76 113 Ardissino G, Vigan S, Testa S, Dacc V, Paglialonga F, Leoni A, et al No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy – report from the ItalKid Project database Nephrol Dial Transplant 2007;22(9):2525–30 114 Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 2004;43(6):1056–64 115 Mokoli VM, Sumaili EK, Lepira FB, Mbutiwi FIN, Makulo JRR, Bukabau JB, et al Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa BMC Nephrol 2018;19(1):68 116 Li P, Chow K-M, Wong T, Leung C-B, Szeto C-C. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis A randomized, controlled study Ann Intern Med 2003;139(2):105–12 117 Litwin M, Grenda R, Sladowska J, Antoniewicz J. Add-on therapy with angiotensin II receptor blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors Pediatr Nephrol 2006;21(11):1716–22 118 Frimodt-Moller M, Hoj Nielsen A, Strandgaard S, Kamper AL. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease Nephrol Dial Transplant 2010;25(3):842–7 I.-S Ha and F Schaefer 119 Bianchi S, Bigazzi R, Campese VM. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases Am J Kidney Dis 2010;55(4):671–81 120 van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients Am J Nephrol 1992;12(5):351–6 121 Flinn A, Ledger S, Blake P. Effectiveness of furosemide in patients on peritoneal dialysis CANNT Js 2006;16(3):40–4 122 Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) Am J Kidney Dis 2007;49(3):426–31 123 Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis Kidney Int 2001;59(3):1128–33 124 Haag-Weber M, Kramer R, Haake R, Islam MS, Prischl F, Haug U, et al Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study Nephrol Dial Transplant 2010;25(7):2288–96 125 Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane Kidney Int 2004;66(1):408–18 126 Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis Cochrane Database Syst Rev 2014;3:CD007554 127 Wang J, Zhu N, Yuan W. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis Nephron 2015;129(3):155–63 128 Yohanna S, Alkatheeri AM, Brimble SK, McCormick B, Iansavitchous A, Blake PG, et al Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis Clin J Am Soc Nephrol 2015;10(8):1380–8 129 Sikaneta T, Wu G, Abdolell M, Ng A, Mahdavi S, Svendrovski A, et al The trio trial – a randomized controlled clinical trial evaluating the effect of a biocompatible peritoneal dialysis solution on residual renal function Perit Dial Int 2016;36(5):526–32 130 McCarthy JT, Jenson BM, Squillace DP, Williams AW. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers Am J Kidney Dis 1997;29(4):576–83 131 Hartmann J, Fricke H, Schiffl H. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis Am J Kidney Dis 1997;30(3):366–73 11 Preservation of Residual Renal Function in Children Reaching End-Stage Renal Disease 132 Schindler R, Boenisch O, Fischer C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo Clin Nephrol 2000;53(6):452–9 133 Hakim RM, Wingard RL, Husni L, Parker RA, Parker TF 3rd The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients J Am Soc Nephrol 1996;7(3):472–8 134 Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients Nephrol Dial Transplant 2002;17(10):1814–8 135 Ng TG, Johnson DW, Hawley CM. Is it time to revisit residual renal function in haemodialysis? Nephrology (Carlton) 2007;12(3):209–17 136 Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients Semin Dial 2004;17(3):196–201 137 Lu W, Ren C, Han X, Yang X, Cao Y, Huang B. The protective effect of different dialysis types on residual renal function in patients with mainte- 171 nance hemodialysis: a systematic review and meta- analysis Medicine 2018;97(37):e12325 138 Ueda A, Nagai K, Hirayama A, Saito C, Yamagata K. Combination therapy with peritoneal dialysis and hemodialysis from the initiation of renal replacement therapy preserves residual renal function and serum albumin Adv Perit Dial 2017;33(2017):74–8 139 Wang X, Zhang X, Lu S, Liu D, Chen G, Dou Y, et al Protective effect of mycophenolate mofetil on residual renal function in peritoneal dialysis patients: an open label feasibility study Nephrology (Carlton) 2017;22(12):954–60 140 Ahmadi F, Abbaszadeh M, Razeghi E, Maziar S, Khoidaki SD, Najafi MT, et al Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial Clin Exp Nephrol 2017;21(2):342–9 141 Feldman L, Shani M, Efrati S, Beberashvili I, Yakov- Hai I, Abramov E, et al N-acetylcysteine improves residual renal function in peritoneal dialysis patients: a pilot study Perit Dial Int 2011;31(5):545–50 Part III Peritoneal Dialysis ... S, Bigazzi R, Campese VM. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases Am J Kidney Dis 2010;55(4):671–81 120 van Olden RW, van Meyel JJ, Gerlag